GSK575594A
SIGMA/SML0262 - ≥98% (HPLC)
Synonym: 1-
CAS Number: 909418-68-4
Empirical Formula (Hill Notation): C24H23F2N3O3S
Molecular Weight: 471.52
Linear Formula: C24H23F2N3O3S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| drug control | regulated under CDSA - not available from Sigma-Aldrich Canada |
| form | powder |
| InChI | 1S/C24H23F2N3O3S/c1-33(31 |
| InChI key | DAPKZHQMEQRNPY-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CS(=O)(=O)c1ccc(-c2ccc(F) |
| solubility | DMSO: ≥5 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | GSK575594A is a selective agonist of human GPR55. |
| Biochem/physiol Actions: | GSK575594A is a selective agonist of human GPR55. It is specific for human over rodent GPR55. GSK575594A had no activity across a set of more than 200 validated molecular target assays from diverse classes including kinases, proteases and other enzymes, GPCRs, ion channels, nuclear receptors, and membrane transporters. |
| Features and Benefits: | This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


